Literature DB >> 30062722

The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats.

Solveig Jandke1,2, Cornelia Garz1,2, Daniel Schwanke1,2, Michael Sendtner3, Hans-Jochen Heinze1,2, Roxana O Carare4, Stefanie Schreiber1,2.   

Abstract

We aimed to test the hypothesis that in spontaneously hypertensive stroke-prone rats (SHRSP), non-amyloid cerebral small vessel disease/hypertensive arteriopathy (HA) results in vessel wall injury that may promote cerebral amyloid angiopathy (CAA). Our study comprised 21 male SHRSP (age 17-44 weeks) and 10 age- and sex-matched Wistar control rats, that underwent two-photon (2PM) imaging of the arterioles in the parietal cortex using Methoxy-X04, Dextran and cerebral blood flow (CBF) measurements. Our data suggest that HA in SHRSP progresses in a temporal and age-dependent manner, starting from small vessel wall damage (stage 1A), proceeding to CBF reduction (stage 1B), non-occlusive (stage 2), and finally, occlusive thrombi (stage 3). Wistar animals also demonstrated small vessel wall damage, but were free of any of the later HA stages. Nearly half of all SHRSP additionally displayed vascular Methoxy-X04 positivity indicative of cortical CAA. Vascular β-amyloid deposits were found in small vessels characterized by thrombotic occlusions (stage 2 or 3). Post-mortem analysis of the rat brains confirmed the findings derived from intravital 2PM microscopy. Our data thus overall suggest that advanced HA may play a role in CAA development with the two small vessel disease entities might be related to the same pathological spectrum of the aging brain.
© 2018 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Entities:  

Keywords:  cerebral amyloid angiopathy; cerebral small vessel disease; hypertensive arteriopathy; intravital imaging; spontaneously hypertensive stroke-prone rat

Mesh:

Substances:

Year:  2018        PMID: 30062722     DOI: 10.1111/bpa.12629

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  11 in total

1.  Connectomic-genetic signatures in the cerebral small vessel disease.

Authors:  Raquel Gutiérrez-Zúñiga; Ibai Diez; Elisenda Bueichekú; Chan-Mi Kim; William Orwig; Victor Montal; Blanca Fuentes; Exuperio Díez-Tejedor; Maria Gutiérrez Fernández; Jorge Sepulcre
Journal:  Neurobiol Dis       Date:  2022-02-26       Impact factor: 5.996

2.  Pulsatility Index in the Basal Ganglia Arteries Increases with Age in Elderly with and without Cerebral Small Vessel Disease.

Authors:  V Perosa; T Arts; A Assmann; H Mattern; O Speck; J Oltmer; H-J Heinze; E Düzel; S Schreiber; J J M Zwanenburg
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-24       Impact factor: 3.825

3.  Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis.

Authors:  Lara Maria Krämer; Johannes Brettschneider; Jochen K Lennerz; Daniel Walcher; Lubin Fang; Angela Rosenbohm; Karthikeyan Balakrishnan; Julian Benckendorff; Peter Möller; Steffen Just; Michael Willem; Albert C Ludolph; Dietmar Rudolf Thal
Journal:  Sci Rep       Date:  2018-11-09       Impact factor: 4.379

4.  A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease.

Authors:  Paul Denver; Heather D'Adamo; Shuxin Hu; Xiaohong Zuo; Cansheng Zhu; Chihiro Okuma; Peter Kim; Daniel Castro; Mychica R Jones; Carmen Leal; Marisa Mekkittikul; Elham Ghadishah; Bruce Teter; Harry V Vinters; Gregory Michael Cole; Sally A Frautschy
Journal:  Front Physiol       Date:  2019-10-24       Impact factor: 4.566

5.  Hypertension and Alzheimer's disease: indirect effects through circle of Willis atherosclerosis.

Authors:  Graham M L Eglit; Alexandra J Weigand; Daniel A Nation; Mark W Bondi; Katherine J Bangen
Journal:  Brain Commun       Date:  2020-07-21

Review 6.  A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage.

Authors:  Humaira Sadaf; Virendra R Desai; Vivek Misra; Eugene Golanov; Muralidhar L Hegde; Sonia Villapol; Christof Karmonik; Angelique Regnier-Golanov; Dimitri Sayenko; Philip J Horner; Robert Krencik; Yi Lan Weng; Farhaan S Vahidy; Gavin W Britz
Journal:  Ann Clin Transl Neurol       Date:  2021-10-14       Impact factor: 4.511

7.  Impact of Non-pharmacological Chronic Hypertension on a Transgenic Rat Model of Cerebral Amyloid Angiopathy.

Authors:  Aleksandra Stanisavljevic; Joseph M Schrader; Xiaoyue Zhu; Jennifer M Mattar; Ashley Hanks; Feng Xu; Mark Majchrzak; John K Robinson; William E Van Nostrand
Journal:  Front Neurosci       Date:  2022-03-15       Impact factor: 4.677

Review 8.  Age-related cerebral small vessel disease and inflammaging.

Authors:  Tiemei Li; Yinong Huang; Wei Cai; Xiaodong Chen; Xuejiao Men; Tingting Lu; Aiming Wu; Zhengqi Lu
Journal:  Cell Death Dis       Date:  2020-10-30       Impact factor: 8.469

9.  In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease.

Authors:  Audrey Low; Elijah Mak; Maura Malpetti; Luca Passamonti; Nicolas Nicastro; James D Stefaniak; George Savulich; Leonidas Chouliaras; Li Su; James B Rowe; Hugh S Markus; John T O'Brien
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-09-11       Impact factor: 10.154

10.  Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.

Authors:  Lene Pålhaugen; Carole H Sudre; Sandra Tecelao; Arne Nakling; Ina S Almdahl; Lisa F Kalheim; M Jorge Cardoso; Stein H Johnsen; Arvid Rongve; Dag Aarsland; Atle Bjørnerud; Per Selnes; Tormod Fladby
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-21       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.